# Simultaneous initiation of finerenone and empagliflozin across the spectrum of kidney risk in the CONFIDENCE trial

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/simultaneous-initiation-of-finerenone-and-empagliflozin-across-the-spectrum-of/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Muthiah Vaduganathan,Jennifer B. Green,Hiddo J.L. Heerspink,Sung Gyun Kim,Johannes F.E. Mann,Janet B. McGill,Amy K. Mottl,Masaomi Nangaku,Julio Rosenstock,Peter Rossing,Li Li,Na Li,Katja Rohwedder,Charlie Scott,Rajiv Agarwal |
| Citations | 6 |
| DOI | 10.1093/ndt/gfaf160 |
| Fields | Medicine |
| Open Access | true |
| OA Status | hybrid |
| OA URL | https://academic.oup.com/ndt/advance-article-pdf/doi/10.1093/ndt/gfaf160/64167336/gfaf160.pdf |
| OpenAlex ID | https://openalex.org/W4413858863 |
| PMID | 40886054 |
| Type | article |
| Year | 2025 |

## Paper authors

- [Muthiah Vaduganathan](https://scholariq.org/researchers/muthiah-vaduganathan/)
- [Peter Rossing](https://scholariq.org/researchers/peter-rossing/)
- [Hiddo J.L. Heerspink](https://scholariq.org/researchers/hiddo-j-l-heerspink/)
- [Masaomi Nangaku](https://scholariq.org/researchers/masaomi-nangaku/)
- [Julio Rosenstock](https://scholariq.org/researchers/julio-rosenstock/)

## Paper funders

Showing 8 of 16.

- [Amgen](https://scholariq.org/funders/amgen/)
- [Eli Lilly and Company](https://scholariq.org/funders/eli-lilly-and-company/)
- [Pfizer](https://scholariq.org/funders/pfizer/)
- [AstraZeneca](https://scholariq.org/funders/astrazeneca/)
- [Bayer](https://scholariq.org/funders/bayer/)
- [Sanofi](https://scholariq.org/funders/sanofi/)
- [Gilead Sciences](https://scholariq.org/funders/gilead-sciences/)
- [Alnylam Pharmaceuticals](https://scholariq.org/funders/alnylam-pharmaceuticals/)

## Paper journal

- [Nephrology Dialysis Transplantation](https://scholariq.org/journals/nephrology-dialysis-transplantation/)

## Paper primary topic

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)

## Paper topics

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)
- [Parathyroid Disorders and Treatments](https://scholariq.org/topics/parathyroid-disorders-and-treatments/)
- [Dialysis and Renal Disease Management](https://scholariq.org/topics/dialysis-and-renal-disease-management/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.